Oral presentation schedule for October 9 (Fri), Day 2
    Grand Prince Hotel New Takanawa International Convention Center PAMIR Grand Prince Hotel Takanawa Grand Prince Hotel New Takanawa    
    Hokushin Keiun Hakuun Suiun Kouun Aoba Matsuba Zuiko Kyokko Gyoko Prince Room Crown Room Ouka Sakura Heian Tenpyo Hiten Amethyst  
    Room 1 Room 2 Room 3 Room 4 Room 5 Room 6 Room 7 Room 8 Room 9 Room 10 Room 11 Room 12 Room 13 Room 14 Room 15 Room 16 Commercial
Exhibition
Room 17  
8:00
                                       
No planned
seminars

Breakfast
Seminar5

AJINOMOTO PHARMA CEUTICALS CO., LTD.
Towards safer and higher quality colonoscopy

Breakfast
Seminar6

Mitsubishi Tanabe Pharma Corporation / AbbVie G.K.
Production of Biologics -Process impacts on product qualit

Breakfast
Seminar7

Sumitomo Dainippon Pharma Co.,Ltd
Intra-arterial therapies for individual conditions of hepatocellular carcinoma

Breakfast
Seminar8

Hitachi Medical Corporation
Evolving pancreaticobiliary endoscopic treatment -What is required of the Interventional Room-

Breakfast
Seminar9

Chugai Pharmaceutical Co., Ltd.
The treatment strategy of colon cancer to liver metastasis

Breakfast
Seminar10

MOCHIDA PHARMACEUTICAL CO.,LTD
The future role of fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease

Breakfast
Seminar11

Sumitomo Dainippon Pharma Co., Ltd.
Strategy for the management of fungal infection in surgical patients

Breakfast
Seminar12

NIHON PHARMACEUTICAL CO., LTD / ASKA Pharmaceutical Co., Ltd.
Usefulness of peppermint oil (MINCLEA®) in transnasal endoscopy

Breakfast
Seminar13

Otsuka Pharmaceutical Factory
Risk management in nutrition therapy
-the significance of administering protein and amino acids-

Breakfast
Seminar14

Bayer Yakuhin, Ltd
Diagnosis and Treatment of HCC: UP-TO-DATE

Breakfast
Seminar15

SHIONOGI & CO.,LTD.
Recent changes of treatment strategies for acute cholangitis and cholecystitis

Breakfast
Seminar16

AsahiKasei Medical Co., Ltd.
A novel stage of CART for refractory ascites.
- Creation of new therapeutic opportunity from palliative care -
         
45
   
 
9:00
                               
30
  Special Lecture(JGES)
Strategy for 50% decrease of gastric cancer related deaths by 2020 in Japan
Lecturer:
M. Asaka
Chair:
N. Sakamoto
W6(JGES/JSGE)
(JGES Core Session)Advanced diagnostic endoscopy in the lower GI tract (small and large intestine) The present evidences and the future perspectives
Chair:
Y. Saitoh
S. Tanaka
Integrated Program 3 (JDDW/JSH/JSGE/JSGS)
Nutritional management to improve therapeutic outcome in patients with chronic liver disease
Chair:
H. Moriwaki
H. Takeyama
PD9(JSGS/JSGE/JGES)
Multimodality treatment for biliary-pancreatic cancer Up-to-date
〈Answer pad〉

Chair:
H. Yamaue
I. Endo
W9(JGES/JSGE)
(JGES Core Session) Interventional EUS: Its evidence and cutting edge
Chair:
T. Mine
N. Fujita
IS-S3
(JSGE/JSH)

Recent progression in drug-induced liver injury (DILI)
Chair:
Y. Matsuzaki
N. Kaplowitz
Live
broadcast
Room 1
PD11(JSGS)
Topics in surgical infections Up-to-date
〈Answer pad〉

Chair:
S. Kusachi
Y. Takesue
Invited Lecture(JSH)
Pathology of Nonalcoholic Steatohepatitis (NASH)
Lecturer:
M. M. Yeh
Chair:
Y. Nakanuma
W11(JSGE/JSH)
Current condition and future trend of clinical metabolomics
Chair:
T. Azuma
H. Ohnishi
PD13
(JSH/JSGE/JSGS)

Minimizing invasiveness of diagnostic and therapeutic modalities for liver diseases
Chair:
F. Moriyasu
M. Kudo
Live
broadcast
Room 2
Live
broadcast
Room 3

    Commercial Exhibition ESD Hands-on seminar 2 (JGES)
JDDW ESD Hands-on seminar for Japanese endoscopists 2
Coordinator:
D. Hirasawa
   
45
  PD8(JGES/JSGE/JSGCS)
Evaluation of "Kyoto Gastritis Classification"
Chair:
T. Akamatsu
K. Murakami
International
Poster
Session
9:30
|
11:30
Digital Poster Session
(JGES)
9:30
|
11:30
Digital Poster Session
(JSGS)
9:30
|
11:30
   
10:00
  IS-W1
(JSH/JSGE)

Pathological features of Nonalcoholic Steatohepatitis (NASH)
Chair:
Y. Nakanuma 
E. Hashimoto
   
     
11:00
     
       
12:00
       
30
                                     
 
13:00
 

Luncheon
Seminar38

Otsuka Pharmaceutical Co., Ltd.
Transitions in the approach to diagnosis and eradication of H. pylori in US and Japan

Luncheon
Seminar39

Takeda Pharmaceutical Company Limited / Otsuka Pharmaceutical Co., Ltd.
What can be treated with gastric acid control and to what extent?

Luncheon
Seminar40

Mitsubishi Tanabe Pharma Corporation
How we can further maintain long-term remission of Crohn's disease patients?
~Theory and Practice~

Luncheon
Seminar41

KYORIN PHARMACEUTICAL CO., LTD
Novel insights into IBD treatment with new data and new form of mesalazine.

Luncheon
Seminar42

Toray Industries, Inc.
Japanese liver diseases treatments entered an evolutionary period on therapeutics
-A future task along with the improvement of curative effect-

Luncheon
Seminar43

Bristol-Myers K.K.
Current conditions of the treatment for chronic hepatitis B

Luncheon
Seminar44

MSD K.K.
The 14th MSD Award Ceremony, Individualize decisions based on CHC pts characteristic regarding DAAs including therapy

Luncheon
Seminar45

Johnson & Johnson K.K.
More Comprehensive New Approach for LADG

Luncheon
Seminar46

Eisai Co., Ltd.
To what extent is the inhibition of acid secretion required ?

Luncheon
Seminar47

Century Medical, Inc.
Radiofrequency Ablation Therapy: The strategy for challenging cases

Luncheon
Seminar48

Cook Japan Inc
Interventional EUS Update -Autumn 2015-

Luncheon
Seminar49

DAIICHI SANKYO CO., LTD
Appropriate Usage of Antibiotics for the Treatment of Gastrointestinal Diseases
Representative
Conference
(Japanese Society
of Gastrointestinal
Cancer Screening)

12:30-13:30
No poster session
during Luncheon Seminars
(12:30-13:40)
   
30
       
40
       
14:00
                                 
 
30
  Lecture by Congress President(JSGS)
Knowledge as action in surgery
Lecturer:
M. Kusunoki
Chair:
K. Sugihara
Special Lecture(JSGE)
The gastronomic meal of the French
Lecturer:
I. Hirota
Chair:
H. Takikawa
W8(JSGE/JGES/JSGS)
Intraductal papillary-mucinous neoplasm versus intraductal papillary neoplasm of the bile duct
Chair:
K. Inui
M. Sugiyama
PD10(JSGS/JSGE/JGES)
Multimodality treatment for colorectal cancer Up-to-date
〈Answer pad〉

Chair:
M. Watanabe
T. Masaki
Special Lecture(JGES)
US health care viewed from a baseball perspective
Lecturer:
K. Lee
Chair:
A. Terano
Invited Lecture(JGES)
Management of Barrett's esophagus, dysplasia and esophageal adenocarcinoma
Lecturer
P. Sharma
Chair:
H. Tajiri
Live
broadcast
Room 1
Invited Lecture(JSGS)
Cancer and the systemic inflammatory response: Past, present and future
Lecturer:
D. C. McMillan
Chair:
K. Hirata
Invited Lecture(JSH)
Metabolic profile of liver disease - NASH and hepatitis C
Lecturer:
J. George
Chair:
K. Koike
W12(JSGE/JSH)
Bile acids in digestive diseases: Relation to pathophysiology, diagnosis, and therapeutics
Chair:
S. Tazuma
M. Unno
Integrated Program 4
(JDDW/JSH/JSGS)

Standerdization of combined modality therapy for advanced hepatocellular carcinoma
Chair:
Y. Ku
T. Torimura
Live
broadcast
Room 2
Women's Committee of Japanese Gastroenterology Study Group
(JDDW)

How to have female doctors and scientists display their ability to the full
Chair:
A. Shiotani
S. Nomura
International
Poster
Session
14:00
|
16:30
Digital Poster Session
(JSGCS)
14:00
|
16:30
Digital Poster Session
(JGES)
14:00
|
16:30
Digital Poster Session
(JSGS)
14:00
|
16:30
Digital Poster Session
(JSH)
14:00
|
16:30
ESD Hands-on seminar 3 (JGES)
JDDW ESD Hands-on seminar for Japanese endoscopists 3
Coordinator:
E. Umegaki
 
 
40
  W5(JSGS/JSGE/JSH/JSGCS)
Translational science; Development of biomarker in the diagnosis and treatment of gastroenterological disease -from bench to bed-
Chair:
Y. Kodera
K. Mimori
 
 
45
  W7(JSGE/JGES)
Recent progress in functional upper gastrointestinal disorder
Chair:
Y. Kinoshita
T. Yamamoto
W10(JGES)
Troubleshooting of interventional endoscopic techniques for pancreaticobiliary diseases〈Video〉
Chair:
H. Maguchi
H. Kawakami
IS-PD1
(JGES/JSGE/JSGS)

Diagnosis and treatment of Barrett epithelium and cancer〈Video〉
Chair:
T. Endo
M. Fujishiro
P. Sharma
PD12(JSGS)
Surgical nutrition and metabolism Up-to-date
〈Answer pad〉

Chair:
T. Higashiguchi
R. Fukushima
 
 
15:00
  IS-W2
(JSH/JSGE)

New trends in diabetes mellitus and liver diseases
Chair:
S. Kaneko
S. Watanabe
 
 
       
16:00
     
       
               
17:00
     
10
                                         
    Japan
Gastroenterological
Endoscopy Society
Awards Ceremony
 
 
30
     
18:00
  Setting up the
JDDW Banquet Room

Satellite
Symposium70

Boston Scientific Japan
Biliary stone management with considering residual stone.

Satellite
Symposium71

FUJIFILM Medical Co., Ltd.
New paradigm shift with LASEREO potential.

Satellite
Symposium72

TAIHO PHARMACEUTICAL CO., LTD.
The Latest Topics and Future Perspective of the Chemotherapy for Gastric cancer

Satellite
Symposium73

Eisai Co., Ltd. / AbbVie GK
HUMIRA Up date of IBD - from physisian and surgeon-

Satellite
Symposium74

Covidien Japan Inc.
The voice from the next generation; how to standardize laparoscopic colorectal surgery

Satellite
Symposium75

Olympus Corporation
To what extent should we enhance the quality of endoscopy in cancer screening

Satellite
Symposium76

AbbVie GK
Toward Eradication of Hepatitis C Virus: Potential of Viekirax Regimen
Incorporated Association
Council and
Academic Council
(Japan Gastroenterological
Endoscopy Society)
17:30-18:45

Satellite
Symposium77

Roche Diagnostics K.K.
The final phase of HCV treatment strategy

Satellite
Symposium78

Yoshida Pharmaceutical Co. Ltd.
Irritable bowel syndrome(IBS) & Microbiome
   
30
  Setting up the
JDDW Banquet Room
Setting up the
JDDW Banquet Room
             
45
                 
19:00
       
30
  Social Gathering (after the Satellite Seminar) Social Gathering (after the Satellite Seminar)                
20:00
         
         

Copyright © JDDW 2015. All Rights Reserved.